Home LiteratureArticle Details
PMID: 17548519 Published · ppublish English Comparative Study Journal Article Research Support, N.I.H., Extramural

MyD88-dependent expansion of an immature GR-1(+)CD11b(+) population induces T cell suppression and Th2 polarization in sepsis.

The Journal of experimental medicine ·Vol. 204 ·No. 6 ·2007-06-11 ·Pages 1463-74

Delano MJ, Scumpia PO, Weinstein JS, Coco D, Nagaraj S, Kelly-Scumpia KM, O'Malley KA, Wynn JL, Antonenko S, Al-Quran SZ, Swan R, Chung CS, Atkinson MA, Ramphal R, Gabrilovich DI, Reeves WH, Ayala A, Phillips J, Laface D, Heyworth PG, Clare-Salzler M, Moldawer LL

Abstract

Polymicrobial sepsis alters the adaptive immune response and induces T cell suppression and Th2 immune polarization. We identify a GR-1(+)CD11b(+) population whose numbers dramatically increase and remain elevated in the spleen, lymph nodes, and bone marrow during polymicrobial sepsis. Phenotypically, these cells are heterogeneous, immature, predominantly myeloid progenitors that express interleukin 10 and several other cytokines and chemokines. Splenic GR-1(+) cells effectively suppress antigen-specific CD8(+) T cell interferon (IFN) gamma production but only modestly suppress antigen-specific and nonspecific CD4(+) T cell proliferation. GR-1(+) cell depletion in vivo prevents both the sepsis-induced augmentation of Th2 cell-dependent and depression of Th1 cell-dependent antibody production. Signaling through MyD88, but not Toll-like receptor 4, TIR domain-containing adaptor-inducing IFN-beta, or the IFN-alpha/beta receptor, is required for complete GR-1(+)CD11b(+) expansion. GR-1(+)CD11b(+) cells contribute to sepsis-induced T cell suppression and preferential Th2 polarization.

MeSH Terms
Animals CD11b Antigen/metabolism Cell Proliferation Colony-Forming Units Assay Cytokines/metabolism Flow Cytometry Immune Tolerance/immunology Lymphoid Tissue/cytology,immunology Mice Mice, Inbred C57BL Myeloid Differentiation Factor 88/metabolism Myeloid Progenitor Cells/immunology,metabolism Receptors, Chemokine/metabolism Sepsis/immunology Signal Transduction/immunology Th2 Cells/immunology
Chemicals
CD11b Antigen Cytokines Gr-1 protein, mouse Myd88 protein, mouse Myeloid Differentiation Factor 88 Receptors, Chemokine
Authors & Affiliations
22 authors, click to expand affiliations / ORCID
Delano Matthew J
Department of Surgery, University of Florida College of Medicine, Gainesville, FL 32610, USA.
Scumpia Philip O
Weinstein Jason S
Coco Dominique
Nagaraj Srinivas
Kelly-Scumpia Kindra M
O'Malley Kerri A
Wynn James L
Antonenko Svetlana
Al-Quran Samer Z
Swan Ryan
Chung Chun-Shiang
Atkinson Mark A
Ramphal Reuben
Gabrilovich Dmitry I
Reeves Wesley H
Ayala Alfred
Phillips Joseph
Laface Drake
Heyworth Paul G
Clare-Salzler Michael
Moldawer Lyle L
References (33)
33 references, click to expand
  1. Prevention of lymphocyte cell death in sepsis improves survival in mice.
    Proc Natl Acad Sci U S A. 1999 Dec 7;96(25):14541-6 PMID: 10588741
  2. The contribution of CD4+ CD25+ T-regulatory-cells to immune suppression in sepsis.
    Shock. 2007 Mar;27(3):251-7 PMID: 17304105
  3. Immune system dysfunction and autoimmune disease in mice lacking Emk (Par-1) protein kinase.
    Mol Cell Biol. 2001 May;21(9):3206-19 PMID: 11287624
  4. Mechanism of immune dysfunction in cancer mediated by immature Gr-1+ myeloid cells.
    J Immunol. 2001 May 1;166(9):5398-406 PMID: 11313376
  5. Sepsis-induced apoptosis causes progressive profound depletion of B and CD4+ T lymphocytes in humans.
    J Immunol. 2001 Jun 1;166(11):6952-63 PMID: 11359857
  6. Targeted adenovirus-induced expression of IL-10 decreases thymic apoptosis and improves survival in murine sepsis.
    Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11503-8 PMID: 11553765
  7. The pathophysiology and treatment of sepsis.
    N Engl J Med. 2003 Jan 9;348(2):138-50 PMID: 12519925
  8. Marked elevation of human circulating CD4+CD25+ regulatory T cells in sepsis-induced immunoparalysis.
    Crit Care Med. 2003 Jul;31(7):2068-71 PMID: 12847405
  9. Inhibition of myeloid cell differentiation in cancer: the role of reactive oxygen species.
    J Leukoc Biol. 2003 Aug;74(2):186-96 PMID: 12885935
  10. All-trans-retinoic acid eliminates immature myeloid cells from tumor-bearing mice and improves the effect of vaccination.
    Cancer Res. 2003 Aug 1;63(15):4441-9 PMID: 12907617
  11. The enigma of sepsis.
    J Clin Invest. 2003 Aug;112(4):460-7 PMID: 12925683
  12. Antigen-specific inhibition of CD8+ T cell response by immature myeloid cells in cancer is mediated by reactive oxygen species.
    J Immunol. 2004 Jan 15;172(2):989-99 PMID: 14707072
  13. Surgical removal of primary tumor reverses tumor-induced immunosuppression despite the presence of metastatic disease.
    Cancer Res. 2004 Mar 15;64(6):2205-11 PMID: 15026364
  14. Diminished bacterial clearance is associated with decreased IL-12 and interferon-gamma production but a sustained proinflammatory response in a murine model of postseptic immunosuppression.
    Shock. 2004 May;21(5):415-25 PMID: 15087817
  15. Promotion of B cell immune responses via an alum-induced myeloid cell population.
    Science. 2004 Jun 18;304(5678):1808-10 PMID: 15205534
  16. Characterization of the systemic loss of dendritic cells in murine lymph nodes during polymicrobial sepsis.
    J Immunol. 2004 Sep 1;173(5):3035-43 PMID: 15322163
  17. Characterization of anti-idiotypic suppressor T cells (Tsid) induced after antigen priming.
    J Immunol. 1984 Sep;133(3):1142-50 PMID: 6205068
  18. Endotoxin and tumour necrosis factor do not cause mortality from caecal ligation and puncture.
    Cytokine. 1994 Sep;6(5):530-6 PMID: 7827289
  19. Structural identification of the hematopoietic progenitor antigen ER-MP12 as the vascular endothelial adhesion molecule PECAM-1 (CD31).
    Eur J Immunol. 1997 Feb;27(2):509-14 PMID: 9045924
  20. T helper cell subset ratios in patients with severe sepsis.
    Intensive Care Med. 1999 Jan;25(1):106-9 PMID: 10051087
  21. Murine leukocytes with ring-shaped nuclei include granulocytes, monocytes, and their precursors.
    J Leukoc Biol. 1999 Feb;65(2):217-31 PMID: 10088605
  22. Overexpression of Bcl-2 in transgenic mice decreases apoptosis and improves survival in sepsis.
    J Immunol. 1999 Apr 1;162(7):4148-56 PMID: 10201940
  23. Increased percentage of CD4+CD25+ regulatory T cells during septic shock is due to the decrease of CD4+CD25- lymphocytes.
    Crit Care Med. 2004 Nov;32(11):2329-31 PMID: 15640650
  24. Regulation of immune responses by L-arginine metabolism.
    Nat Rev Immunol. 2005 Aug;5(8):641-54 PMID: 16056256
  25. CD11c+ dendritic cells are required for survival in murine polymicrobial sepsis.
    J Immunol. 2005 Sep 1;175(5):3282-6 PMID: 16116220
  26. Tumor-associated CD8+ T cell tolerance induced by bone marrow-derived immature myeloid cells.
    J Immunol. 2005 Oct 1;175(7):4583-92 PMID: 16177103
  27. CD11b+/Gr-1+ myeloid suppressor cells cause T cell dysfunction after traumatic stress.
    J Immunol. 2006 Feb 15;176(4):2085-94 PMID: 16455964
  28. Splenic CD4+ T cells have a distinct transcriptional response six hours after the onset of sepsis.
    J Am Coll Surg. 2006 Sep;203(3):365-75 PMID: 16931309
  29. All-trans-retinoic acid improves differentiation of myeloid cells and immune response in cancer patients.
    Cancer Res. 2006 Sep 15;66(18):9299-307 PMID: 16982775
  30. TCR zeta down-regulation under chronic inflammation is mediated by myeloid suppressor cells differentially distributed between various lymphatic organs.
    J Immunol. 2006 Oct 1;177(7):4763-72 PMID: 16982917
  31. Increased natural CD4+CD25+ regulatory T cells and their suppressor activity do not contribute to mortality in murine polymicrobial sepsis.
    J Immunol. 2006 Dec 1;177(11):7943-9 PMID: 17114466
  32. The terminology issue for myeloid-derived suppressor cells.
    Cancer Res. 2007 Jan 1;67(1):425; author reply 426 PMID: 17210725
  33. Identification of a CD11b(+)/Gr-1(+)/CD31(+) myeloid progenitor capable of activating or suppressing CD8(+) T cells.
    Blood. 2000 Dec 1;96(12):3838-46 PMID: 11090068
Article Info
Journal
The Journal of experimental medicine
Abbr.
J Exp Med
ISSN
0022-1007
Published
2007-06-11
Epub
2007-00-04
Pages
1463-74
Language
English
Region
United States
NLM ID
2985109R
PMCID
PMC2118626
Subset
IM
Grants
NIGMS NIH HHS · R37 GM040586 · United States
NIGMS NIH HHS · R01 GM046354 · United States
NIGMS NIH HHS · R01GM-46354 · United States
NIGMS NIH HHS · T32GM-08431 · United States
NIGMS NIH HHS · R01GM-62041 · United States
NIGMS NIH HHS · R37GM-40586 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]